Cargando…
An evaluation of the robustness of organ-at-risk recommendations made by GEC/ESTRO according to interobserver variability: a single-center experience
PURPOSE: Groupe Européen de Curiethérapie (GEC) and European Society for Radiotherapy & Oncology (ESTRO) has proposed a rectal dose constraint of the most exposed 2-cc volume (D(2cc) of ≤ 75 Gy EQD(2α/β) = 3) during external-beam plus high-dose-rate brachytherapy (HDR-BT) in localized prostate c...
Autores principales: | Chicas-Sett, Rodolfo, Celada-Alvarez, Francisco, Roldán, Susana, Torregrosa, Asunción, Betancourt, Jesus, Bautista-Ballesteros, Juan, Farga, Dolores, Ibañez, Blanca, Tormo, Alejandro, Perez-Calatayud, Jose |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5018524/ https://www.ncbi.nlm.nih.gov/pubmed/27648090 http://dx.doi.org/10.5114/jcb.2016.61738 |
Ejemplares similares
-
Review of clinical brachytherapy uncertainties: Analysis guidelines of GEC-ESTRO and the AAPM()
por: Kirisits, Christian, et al.
Publicado: (2014) -
GEC ESTRO ACROP consensus recommendations for contact brachytherapy for rectal cancer
por: Stewart, Alexandra J., et al.
Publicado: (2021) -
Intravascular Biphasic Synovial Sarcoma: The Beneficial Role of Adjuvant Treatment Approach in the Pre-metastatic Stage
por: Chicas-Sett, Rodolfo, et al.
Publicado: (2016) -
Equivalence of Gyn GEC-ESTRO guidelines for image guided cervical brachytherapy with EUD-based dose prescription
por: Shaw, William, et al.
Publicado: (2013) -
Brachytherapy boost in anal canal cancer – A GEC ESTRO PDR task force meta-analysis
por: Annede, Pierre, et al.
Publicado: (2023)